Programmed cell death in autoimmune diseases

Autoimmunity Reviews · Published 2026-07-25 · DOI 10.1016/j.autrev.2026.104145

Authors (2)

Xiaoyu Cai, Yao Yao

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Cai, X., Yao, Y. (2026). Programmed cell death in autoimmune diseases. Autoimmunity Reviews. https://doi.org/10.1016/j.autrev.2026.104145

Related articles

• The glucocorticoid dexamethasone inhibits HIF-1α stabilization and metabolic reprogramming in lipopolysaccharide-stimulated primary macrophages · Discovery Immunology · 2023 · Cites or is cited by this article
• Chimeric Antigen Receptor T Cell Therapy in Systemic Lupus Erythematosus: Mechanisms, Clinical Advances, and Future Directions a Comprehensive Review · Clinical Reviews in Allergy and Immunology · 2025 · Cites or is cited by this article
• IL-1 family cytokines in inflammation and immunity · Cellular and Molecular Immunology · 2025 · Cites or is cited by this article
• Therapeutic Potential of Nanocarriers in the Management of Rheumatoid Arthritis · Current Rheumatology Reviews · 2024 · Cites or is cited by this article
• Metabolic regulatory nodes of the inflammasome and inflammatory cell death · Trends in Immunology · 2026 · Cites or is cited by this article
• Endosome traffic in rheumatic diseases: mechanistic insights and therapeutic opportunities · Nature Reviews Rheumatology · 2025 · Cites or is cited by this article
• Rewiring immunometabolism in hepato-biliary-pancreatic cancers: Unraveling TME-mediated metabolic suppression and advancing next-generation immunotherapeutic approaches · Autoimmunity Reviews · 2026 · Same journal
• Predicting the course: Real-world trajectories toward minimal disease activity in psoriatic arthritis · Autoimmunity Reviews · 2026 · Same journal
• The future of TCR-Treg therapies is renewables · Autoimmunity Reviews · 2026 · Same journal
• Pathological reprogramming of innate immune cells drives resistance to biologics in inflammatory bowel diseases · Autoimmunity Reviews · 2026 · Same journal